The biaryl structural motif is a predominant feature in many pharmaceutically relevant and biologically active compounds. As a result, for over a century 1 organic chemists have sought to develop new and more efficient aryl -aryl bond-forming methods. Although there exist a variety of routes for the construction of aryl -aryl bonds, arguably the most common method is through the use of transition-metalmediated reactions. 2-4 While earlier reports focused on the use of stoichiometric quantities of a transition metal to carry out the desired transformation, modern methods of transitionmetal-catalyzed aryl -aryl coupling have focused on the development of high-yielding reactions achieved with excellent selectivity and high functional group tolerance under mild reaction conditions. Typically, these reactions involve either the coupling of an aryl halide or pseudohalide with an organometallic reagent (Scheme 1), or the homocoupling of two aryl halides or two organometallic reagents. Although a number of improvements have developed the former process into an industrially very useful and attractive method for the construction of aryl -aryl bonds, the need still exists for more efficient routes whereby the same outcome is accomplished, but with reduced waste and in fewer steps. In particular, the obligation to use coupling partners that are both activated is wasteful since it necessitates the installation and then subsequent disposal of stoichiometric activating agents. Furthermore, preparation of preactivated aryl substrates often requires several steps, which in itself can be a time-consuming and economically inefficient process.

http://aether.cmi.ua.ac.be/artikels/Artikels%20Gitte/Artikels/Reviews/Heck-Type-lautens.pdf

Aryl-aryl bond formation by transition-metal-catalyzed direct arylation.

A rotationally hindered and thus stereogenic biaryl axis is the structurally and stereochemically decisive element of a steadily growing number of natural products, chiral auxiliaries, and catalysts. Thus, it is not surprising that significant advances have been made in the asymmetric synthesis of axially chiral biaryl compounds over the past decade. In addition to the classic approach (direct stereoselective aryl-aryl coupling), innovative concepts have been developed in which the asymmetric information is introduced into a preformed, but achiral-that is, symmetric or configurationally labile-biaryl compound, or in which an aryl--C single bond is stereoselectively transformed into an axis. This Review classifies these strategies according to their underlying concepts and critically evaluates their scope and limitations with reference to selected model reactions and applications. Furthermore, the preconditions required for the existence of axial chirality in biaryl compounds are discussed.

Atroposelective Synthesis of Axially Chiral Biaryl Compounds

With the long-term goal of producing nanometer-scale machines, we describe here the unidirectional rotary motion of a synthetic molecular structure fueled by chemical conversions. The basis of the rotation is the movement of a phenyl rotor relative to a naphthyl stator about a single bond axle. The sense of rotation is governed by the choice of chemical reagents that power the motor through four chemically distinct stations. Within the stations, the rotor is held in place by structural features that limit the extent of the rotor's Brownian motion relative to the stator.

/pdf/a-reversible-unidirectional-molecular-rotary-motor-driven-by-1jmmv3w33f.pdf

A Reversible, Unidirectional Molecular Rotary Motor Driven by Chemical Energy

Dynamic kinetic resolution

Eine rotationsgehinderte und dadurch stereogene Biarylachse ist das strukturell und stereochemisch entscheidende Element einer standig wachsenden Zahl von Naturstoffen, chiralen Auxiliaren und Katalysatoren. Daher ist es nicht uberraschend, dass im letzten Jahrzehnt bedeutende Fortschritte in der asymmetrischen Synthese axial-chiraler Biaryle erzielt worden sind. Neben dem klassischen Zugangsweg, der direkten Aryl-Aryl-Kupplung, sind innovative Konzepte entwickelt worden, in denen die asymmetrische Information in ein schon vorhandenes, aber nicht optisch aktives – symmetrisches oder konfigurativ labiles – Biaryl eingefuhrt oder eine Aryl-C-Einfachbindung stereoselektiv in eine Achse umgewandelt wird. In diesem Aufsatz werden die Strategien nach den zugrunde liegenden Konzepten klassifiziert, und ihre Anwendungsbreite und ihre Beschrankungen werden anhand ausgewahlter Beispiele kritisch beurteilt. Ferner werden die Voraussetzungen fur das Auftreten von Axialchiralitat diskutiert.

Atropselektive Synthese axial‐chiraler Biaryle

Atropo-enantioselective biaryl synthesis by stereocontrolled cleavage of configuratively labile lactone-bridged precursors using chiral H-nucleophiles

https://opus.bibliothek.uni-wuerzburg.de/files/4070/Burschka_Biaryl_synthesis_9.pdf

Novel Concepts in Directed Biaryl Synthesis, IX. Synthesis and Structure of Benzonaphthopyranones, Useful Bridged Model Precursors for Stereoselective Biaryl Syntheses

Erste atrop‐enantioselektive Ringöffnung achiraler Lacton‐verbrückter Biaryle mit chiralen Boranabgeleiteten Hydridübertragungsreagentien

Novel Concepts in Directed Biaryl Synthesis, XVI. Synthesis and Structure of Benzonaphthopyrans; Helically Distorted, Bridged Biaryls with Different Steric Hindrance at the Axis

Thomas Hartung

Papers

Atropo-enantioselective biaryl synthesis by stereocontrolled cleavage of configuratively labile lactone-bridged precursors using chiral H-nucleophiles

Novel Concepts in Directed Biaryl Synthesis, IX. Synthesis and Structure of Benzonaphthopyranones, Useful Bridged Model Precursors for Stereoselective Biaryl Syntheses

Erste atrop‐enantioselektive Ringöffnung achiraler Lacton‐verbrückter Biaryle mit chiralen Boranabgeleiteten Hydridübertragungsreagentien

Novel Concepts in Directed Biaryl Synthesis, XVI. Synthesis and Structure of Benzonaphthopyrans; Helically Distorted, Bridged Biaryls with Different Steric Hindrance at the Axis

Synthesis and absolute stereostructure of dinaphth[2,1- c: 1′,2′-e]oxepin-3-(5H)-one